MZMax Xiaohang Zhao

Max Xiaohang Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Max Xiaohang Zhao has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • Denise Horn

    Charité – Universitäts medizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Genetics and Human Genetics

    2 shared publications
  • Giulia Guidi

    Department of Computer Science, Cornell University, 107 Hoy Rd, Ithaca, 14853, New York, USA

    2 shared publications
  • Jean Tori Pantel

    Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany

    2 shared publications
  • Max Schubach

    Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany

    2 shared publications
  • Nicole Fleischer

    FDNA Inc., Boston, MA, USA

    2 shared publications
  • Nurulhuda Hajjir

    Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Medical Genetics and Human Genetics, Berlin, Germany

    2 shared publications

Latest Publications

  • Open Access

    Sparse Linear Algebra Accelerates Genotype Representation Graph Computation at Biobank Scale

    by Yifan Li, Qingyao Sun, Drew DeHaas, Max Xiaohang Zhao, Adam R. Boyko, Shaila A. Musharoff, Xinzhu Wei, Giulia Guidi

    Biobank-scale genomic analyses are increasingly constrained by computational costs, as hundreds of thousands to millions of samples and variants must be analyzed together. The genotype representation graph (GRG) compactly encodes population genetic variation to accelerate computation, but its graph-traversal implementation does not exploit modern accelerators. This work introduces M ikado , a methodology that expresses GRG-based computation using sparse linear algebra primitives. Under a reverse topological ordering, the GRG adjacency matrix is strictly block-lower-triangular, and the genotype matrix-vector product becomes a sparse triangular solve, decomposed into a pipelined sequence of blocked sparse matrix-vector multiplies. Because GRGs are shallow by construction, the solve completes in only a few sequential stages, exposing fine-grained parallelism and enabling vendor-optimized sparse primitives on GPUs. On the full All of Us cohort, M ikado computes principal components in minutes , where PLINK2 cannot complete one chromosome in 72 hours, and runs genome-wide BOLT-LMM-inf in under 19 minutes on one GPU, where the official BOLT-LMM analysis would be impractical. Our two-stage reformulation is independent of the hardware: the same code runs unchanged across GPU architectures and, on CPUs, gives a 1.8 × single-threaded speedup over the existing GRG library together with multi-threaded scaling, providing a scalable, portable approach for population genetics as biobanks continue to grow.

  • Open Access

    mehari: high-performance, strict HGVS-first variant effect prediction

    by Till Frederik Hartmann, Max Xiaohang Zhao, Dieter Beule, Manuel Holtgrewe

    Variant annotation requires the precise and consistent computation of Sequence Ontology (SO) terms and Human Genome Variation Society (HGVS) nomenclature. To ensure robust synchronization between these two key facets, we present mehari, a high-performance variant effect predictor implemented in Rust that employs a strict "HGVS-first" approach. By deterministically projecting variants to transcripts before evaluating functional consequences, mehari structurally aligns HGVS notation and SO terms. Benchmarking on ClinVar demonstrates that mehari achieves exceptional processing speeds and high concordance with established tools like Ensembl VEP, while also providing refined handling for complex biological edge cases such as selenoprotein recoding.

  • Open Access

    Space Efficient Sequence Alignment for SRAM-Based Computing: X-Drop on the Graphcore IPU

    by Luk Burchard, Max Xiaohang Zhao, Johannes Langguth, Aydın Buluç, Giulia Guidi

    Dedicated accelerator hardware has become essential for processing AI-based workloads, leading to the rise of novel accelerator architectures. Furthermore, fundamental differences in memory architecture and parallelism have made these accelerators targets for scientific computing. The sequence alignment problem is fundamental in bioinformatics; we have implemented the X-Drop algorithm, a heuristic method for pairwise alignment that reduces search space, on the Graphcore Intelligence Processor Unit (IPU) accelerator. The X-Drop algorithm has an irregular computational pattern, which makes it difficult to accelerate due to load balancing. Here, we introduce a graph-based partitioning and queue-based batch system to improve load balancing. Our implementation achieves 10× speedup over a state-of-the-art GPU implementation and up to 4.65× compared to CPU. In addition, we introduce a memory-restricted X-Drop algorithm that reduces memory footprint by 55× and efficiently uses the IPU's limited low-latency SRAM. This optimization further improves strong scaling by 3.6×.


  • Open Access

    PEDIA: prioritization of exome data by image analysis

    by Tzung-Chien Hsieh, Martin A. Mensah, Jean T. Pantel, Dione Aguilar, Omri Bar, Allan Bayat, Luis Becerra-Solano, Heidi B. Bentzen, Saskia Biskup, Oleg Borisov, et al.


  • Open Access

    Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis

    by Alexej Knaus, Jean Tori Pantel, Manuela Pendziwiat, Nurulhuda Hajjir, Max Zhao, Tzung-Chien Hsieh, Max Schubach, Yaron Gurovich, Nicole Fleischer, Marten Jäger, et al.

    Glycosylphosphatidylinositol biosynthesis defects (GPIBDs) cause a group of phenotypically overlapping recessive syndromes with intellectual disability, for which pathogenic mutations have been described in 16 genes of the corresponding molecular pathway. An elevated serum activity of alkaline phosphatase (AP), a GPI-linked enzyme, has been used to assign GPIBDs to the phenotypic series of hyperphosphatasia with mental retardation syndrome (HPMRS) and to distinguish them from another subset of GPIBDs, termed multiple congenital anomalies hypotonia seizures syndrome (MCAHS). However, the increasing number of individuals with a GPIBD shows that hyperphosphatasia is a variable feature that is not ideal for a clinical classification. We studied the discriminatory power of multiple GPI-linked substrates that were assessed by flow cytometry in blood cells and fibroblasts of 39 and 14 individuals with a GPIBD, respectively. On the phenotypic level, we evaluated the frequency of occurrence of clinical symptoms and analyzed the performance of computer-assisted image analysis of the facial gestalt in 91 individuals. We found that certain malformations such as Morbus Hirschsprung and diaphragmatic defects are more likely to be associated with particular gene defects (PIGV, PGAP3, PIGN). However, especially at the severe end of the clinical spectrum of HPMRS, there is a high phenotypic overlap with MCAHS. Elevation of AP has also been documented in some of the individuals with MCAHS, namely those with PIGA mutations. Although the impairment of GPI-linked substrates is supposed to play the key role in the pathophysiology of GPIBDs, we could not observe gene-specific profiles for flow cytometric markers or a correlation between their cell surface levels and the severity of the phenotype. In contrast, it was facial recognition software that achieved the highest accuracy in predicting the disease-causing gene in a GPIBD. Due to the overlapping clinical spectrum of both HPMRS and MCAHS in the majority of affected individuals, the elevation of AP and the reduced surface levels of GPI-linked markers in both groups, a common classification as GPIBDs is recommended. The effectiveness of computer-assisted gestalt analysis for the correct gene inference in a GPIBD and probably beyond is remarkable and illustrates how the information contained in human faces is pivotal in the delineation of genetic entities.